Follow us...

 

Search News Archives

Channels

News

 

 

View Channel

Laboratory Products

 

 

View Channel

Special Offers and Promotions

 

Microscopy | Image Analysis

 

 

View Channel

Separation Science

 

 

View Channel

Coronavirus (COVID-19)

 

 

View Channel

Research & Case Studies

 

 

View Channel

Brochures & Literature

 

 

View Channel

 

Conferences | Events

Unite urges the government to bat for advanced British manufacturing

publication date: May 2, 2014
 | 
author/source: Unite

Unite, Britain’s biggest union, has urged the government to ‘bat for advanced British manufacturing’ as AstraZeneca rejected yet another approach from Pfizer.

UniteNews of the renewed bid is causing major concerns amongst almost 7,000 staff in the UK. Back in 2011 when Pfizer closed its world class research and development site in Kent at short notice, there was very little consultation with the 2,400 strong workforce. Coupled with weak employment laws it meant the UK lost valuable highly skilled jobs and research and development capabilities.
 
Unite national officer Linda McCulloch said: “Despite AstraZeneca’s latest rejection, Pfizer has its sights on this strategically important UK owned company. We’ve written to the business secretary Vince Cable asking for a urgent meeting to discuss our members’ concerns.
 
“AstraZeneca embodies the UK government’s vision of advanced manufacturing. We are not convinced that Pfizer’s bid is anything more than an attempt by a US company to reduce its taxes by buying into a UK owned company.
 
“We expect the government to bat for Britain’s advanced manufacturing base. It is in the national interest for this government to study this bid meticulously. Shareholders have no loyalty to the UK, and our corporate culture encourages this, whereas in other EU countries like France the government will act on takeovers if it feels it is not in the national interest.
 
“Despite warm words about Pfizer’s commitments to the UK we remain extremely concerned about the impact on jobs and the long term effect on research and development if Pfizer’s bid succeeds. When Pfizer closed its world class research & development site in Kent back in 2011 there was very little consultation and it was done at very short notice.”


more about Unite


 



 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month...

Our Top 10 most popular articles this month

 

Today's Picks...

 

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners